Back to Selection     Print       Date : 31 Oct 2025
Fund Summary
Nippon India Pharma Fund (G)
[Equity: Sectoral]  
 
Fund Details
Fund Type Growth Launch Date 05-Jun-04
Corpus(Cr.) 8346.0 Latest NAV 515.1984 As on 05-12-2025
Equity(%) 99.67 52 Week High 536.807
Debt(%) 0.33 52 Week Low 451.81
Others(%) 0.0 Exit Load 1% for redemption within 30 days
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 1.80
Scheme Benchmark BSE Healthcare TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Sailesh Raj Bhan
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 40.26%
Top 10 Holdings 58.54%
Top 25 Holdings 90.45%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Pharma & Biotech 75.07
Healthcare 21.28
Retail 3.32
Cash 0.33
 
 
 
 
 
Portfolio Metrics
PB Ratio 5.49
PE Ratio 37.13
 
Top 25 Holdings
Holdings Net Asset(%)
Sun Pharmaceutical Industries Limited 12.67
DIVI LABORATORIES LTD 8.07
Lupin Limited 7.26
Cipla Limited 6.29
Apollo Hospitals Enterprise Limited 5.97
Dr Reddys Laboratories Limited 5.62
Vijaya Diagnostic Centre Limited 3.42
MedPlus Health Services Limited 3.32
Gland Pharma Limited 3.05
Glaxosmithkline Pharma Ltd 2.87
Ajanta Pharma Limited 2.83
Sai Life Sciences Limited 2.81
Thyrocare Technologies Limited 2.59
Abbott India Limited 2.39
Aurobindo Pharma Limited 2.32
Dr Lal Path Labs Ltd 2.29
Mankind Pharma Limited 2.16
Alkem Laboratories Limited 2.14
Biocon Limited 2.10
J B Chemicals and Pharma Ltd 2.01
Pfizer Limited 1.99
Narayana Hrudalaya Ltd 1.95
IPCA Laboratories Limited 1.50
SURAKSHA DIAGNOSTIC LTD 1.48
Fortis Health Care Ltd 1.35

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
0.24% 0.34% 1.35% -0.32%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
2.70% 6.00% 5.46% 7.43%
 
Scheme Benchmark [BSE Healthcare TRI]
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
17.03% 21.17% 16.10% 13.46%
 
 
13.19% 13.29% 15.94% 14.28%
 
 
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
Nippon India Pharma Fund (G) 15.24% 0.9986 10.1550% 45.0609 0.1448
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
Nippon India Pharma Fund (G) 11.1995% 0.0002 0.2797 14.4367 0.6968
 
Back to Selection